| 25.12 -0.23 (-0.91%) | 10-15 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 36.62  |
1-year : | 41.9 |
| Resists | First : | 31.35 |
Second : | 35.88 |
| Pivot price | 32.21 |
|||
| Supports | First : | 24.04 | Second : | 20 |
| MAs | MA(5) : | 28.99 |
MA(20) : | 32.77 |
| MA(100) : | 41.5 |
MA(250) : | 43.7 |
|
| MACD | MACD : | -2.9 |
Signal : | -2.3 |
| %K %D | K(14,3) : | 13.4 |
D(3) : | 25 |
| RSI | RSI(14): 23 |
|||
| 52-week | High : | 70.26 | Low : | 24.04 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PDEX ] has closed below the lower bollinger band by 3.5%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ PDEX ] is to continue within current trading range. It is unclear right now based on current values. 42.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 26.02 - 26.27 | 26.27 - 26.42 |
| Low: | 24.07 - 24.39 | 24.39 - 24.58 |
| Close: | 24.75 - 25.28 | 25.28 - 25.59 |
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Tue, 14 Oct 2025
Pro-Dex's (NASDAQ:PDEX) earnings growth rate lags the 10.0% CAGR delivered to shareholders - simplywall.st
Tue, 09 Sep 2025
Earnings Working Against Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Following 26% Dive - simplywall.st
Thu, 04 Sep 2025
Pro-Dex Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 04 Sep 2025
Pro-Dex, Inc. (PDEX) Lags Q4 Earnings and Revenue Estimates - Nasdaq
Tue, 29 Jul 2025
Strength Seen in ProDex (PDEX): Can Its 8.2% Jump Turn into More Strength? - Yahoo Finance
Fri, 30 May 2025
Declining Stock and Decent Financials: Is The Market Wrong About Pro-Dex, Inc. (NASDAQ:PDEX)? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 3 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 35.5 (%) |
| Held by Institutions | 32.4 (%) |
| Shares Short | 263 (K) |
| Shares Short P.Month | 260 (K) |
| EPS | 2.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.22 |
| Profit Margin | 13.4 % |
| Operating Margin | 7.6 % |
| Return on Assets (ttm) | 11.7 % |
| Return on Equity (ttm) | 26.6 % |
| Qtrly Rev. Growth | 16.3 % |
| Gross Profit (p.s.) | 5.94 |
| Sales Per Share | 20.3 |
| EBITDA (p.s.) | 3.63 |
| Qtrly Earnings Growth | -22.4 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | 9.4 |
| PEG Ratio | 0 |
| Price to Book value | 2.23 |
| Price to Sales | 1.23 |
| Price to Cash Flow | -49.05 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|